05/27/2021
This month, published an article on exciting new research:
"The study, the first Phase 3 clinical trial conducted with psychedelic-assisted therapy, found that M**A paired with counseling brought marked relief to patients with severe post-traumatic stress disorder.
Psychedelic drugs are on the cusp of entering mainstream psychiatry, with profound implications for a field that in recent decades has seen few pharmacological advancements for the treatment of mental disorders and addiction. The need for new therapeutics has gained greater urgency amid a national epidemic of opioid abuse and suicides.
Psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy. They also induce neuroplasticity, the brain’s ability to change and reorganize thought patterns, enabling people with psychological disorders to find new ways to process anxiety, depression or deeply embedded trauma.
They say it is only a matter of time before the FDA grants approval for psychoactive compounds to be used therapeutically — for M**A as soon as 2023, followed by psilocybin a year or two later."
Link in bio for full article.
🌵🍄🌿 DM if you are interested in working with me on psychedelic integration therapy. I offer preparation, intention, and psychedelic integration therapy— I do not offer psychedelic assisted therapy or the distribution of illegal substances.
